Bruker (BRKR) Non Operating Investment Income (2026)
Bruker (BRKR) posted Non Operating Investment Income of $12.2 million for Q1 2026.
Bruker (BRKR) Non Operating Investment Income (2026) Analysis & Trends
Bruker's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at $12.2 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.35 Bn | 180.06 Bn | 6.27 Bn | - |
| 2 | Stryker | 132.18 Bn | 129.31 Bn | 3.81 Bn | - |
| 3 | Medtronic | 111.47 Bn | 102.25 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.97 Bn | 67.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.83 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.00 Bn | 27.88 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.78 Bn | 26.49 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 28.00 Bn | 27.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.22 Bn | 2.01 Bn | - |
| 10 | Bruker | 9.40 Bn | 9.40 Bn | 379.80 Mn | 12.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.20 Mn |
| Mar 31, 2026 | 12.20 Mn |